Minnetronix, Inc. Announces Expansion

October 7, 2013

ST. PAUL, Minn. October 7, 2013 — Minnetronix, a leading medical device design, manufacturing and IP innovation services firm, is excited to announce the expansion of its corporate headquarters in St. Paul, Minn., bringing the firm’s total space to just over 120,000 sq. ft.

The addition of a 65,000 sq. ft. facility represents the third expansion within seven years to accommodate the company’s growth. This expansion allows Minnetronix to continue to increase its offerings and to enhance its presence and impact in the local community and medical device marketplace.

Focusing 100 percent on the medical device and life science industries, Minnetronix helps customers extend and strengthen their ability to develop and deliver medical technology to the marketplace with award-winning design, engineering and manufacturing services.

Most recently, Minnetronix introduced its IP technology portfolio as a solution to unmet customer needs. Such examples of the firm’s IP portfolio include the Minnetronix® Cognita™ wireless monitoring system, wireless energy transmission technology (TETS) for Congestive Heart Failure, and the recent acquisition of Neurofluidics. By identifying and pursuing unique solutions to various challenges facing the operational and clinical markets, Minnetronix continues to create a rapidly developing services and technology portfolio that benefits its design and manufacturing customers, as well as patients.

According to Minnetronix’ CEO Rich Nazarian, “Minnetronix has experienced substantial growth over the past five years and we are poised for much more. Successfully partnering with our customers to deliver innovative medical technology to patients around the world has resulted in substantial business growth. This allows us to support the continued expansion of our facility, enhancing our offerings to customers in a positive and dynamic environment for our team.”

The new facility opened in mid-September.

About Minnetronix

Founded in 1996 with the mission of rapidly developing and manufacturing technologically advanced medical devices, Minnetronix has helped customers transform ideas into commercial success within the medical device and life science marketplaces for over 15 years.

Leading over 200 design and manufacturing projects for more than 150 firms varying from small start-ups to large established firms, Minnetronix’ experienced engineers and manufacturing teams incorporate custom electronic, mechanical and software engineering into finished Class II & III devices and systems such as cardiovascular and monitoring systems, therapeutic and implantable devices, and diagnostic instruments, among others.

Included in a broad base of customers are Cardiovascular Systems, Cleveland Clinic, MEDRAD Interventional, Medtronic, St. Jude Medical, and numerous others.

Minnetronix is ISO 13485 certified and FDA registered.